DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,409 | +1.9% | 25,834 | -1.4% | 4.16% | +0.1% |
| Q2 2023 | $6,291 | -4.8% | 26,211 | 0.0% | 4.16% | -13.6% |
| Q1 2023 | $6,606 | -5.9% | 26,211 | -0.9% | 4.82% | -7.7% |
| Q4 2022 | $7,023 | -99.9% | 26,461 | 0.0% | 5.22% | +2.6% |
| Q3 2022 | $6,835,000 | +1.9% | 26,461 | -0.0% | 5.09% | +12.4% |
| Q2 2022 | $6,709,000 | -14.4% | 26,462 | -1.0% | 4.52% | -1.0% |
| Q1 2022 | $7,841,000 | -14.3% | 26,732 | -3.9% | 4.57% | -13.5% |
| Q4 2021 | $9,151,000 | +3.8% | 27,815 | -4.0% | 5.28% | -5.9% |
| Q3 2021 | $8,820,000 | +12.2% | 28,972 | -1.1% | 5.61% | +14.8% |
| Q2 2021 | $7,862,000 | -41.0% | 29,297 | -50.6% | 4.89% | +10.8% |
| Q1 2021 | $13,336,000 | +99.2% | 59,248 | +96.6% | 4.42% | -8.5% |
| Q4 2020 | $6,695,000 | +2.2% | 30,140 | -0.9% | 4.82% | -11.6% |
| Q3 2020 | $6,548,000 | +19.1% | 30,411 | -2.2% | 5.46% | +7.8% |
| Q2 2020 | $5,499,000 | +14.8% | 31,098 | -10.2% | 5.06% | -0.4% |
| Q1 2020 | $4,791,000 | -14.3% | 34,616 | -5.0% | 5.08% | +4.3% |
| Q4 2019 | $5,593,000 | +4.2% | 36,445 | -1.9% | 4.88% | -4.2% |
| Q3 2019 | $5,368,000 | -6.2% | 37,164 | -7.2% | 5.09% | -5.3% |
| Q2 2019 | $5,723,000 | +8.2% | 40,044 | -0.0% | 5.37% | -0.4% |
| Q1 2019 | $5,287,000 | +22.6% | 40,049 | -4.2% | 5.39% | +331.8% |
| Q4 2018 | $4,312,000 | – | 41,823 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |